Anti-CD38 Antibody (Mezagitamab)
Catalog No.
F1169
Anti-CD38 Antibody (Mezagitamab)
Featured Products
Mezagitamab (TAK-079) is an IgG1λ anti-CD38 monoclonal antibody. Mezagitamab depletes tumor cells expressing CD38 through antibody and complement-dependent cytotoxicity. Mezagitamab has potential applications in relapsed/refractory multiple myeloma (RRMM) and idiopathic thrombocytopenic purpura (ITP).
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
2227490-52-8
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
TAK 079, TAK-079
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P28907
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human CD38 NHis at 2 ug/mL can bind Anti-CD38 Antibody (Mezagitamab)
CD38
Please avoid freeze-thaw cycles.